Zhi-Yong Peng1, Melinda J Carter, John A Kellum. 1. The Clinical Research, Investigation, and Systems Modeling of Acute Illness Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Abstract
OBJECTIVE: A broad-spectrum immune-regulating therapy could be beneficial in the treatment of sepsis. Our previous studies have shown that a hemoadsorption device (CytoSorb) removes both pro- and anti-inflammatory cytokines and improves survival in experimental endotoxemia. We sought to determine whether hemoadsorption can also be effective in the treatment of sepsis. DESIGN: Randomized controlled laboratory experiment. SETTING: University laboratory. INTERVENTIONS: Rats were subjected to cecal ligation and puncture (CLP) and 20 hrs later were randomized to receive either hemoadsorption or sham treatment using an arterial-venous circuit. Hemoadsorption was accomplished using a cartridge containing Cytosorb beads. Blood was drawn for cytokine measurements and mean arterial pressure (MAP) was continuously monitored. Cytokines were measured via multiplex bead immunoassays. Survival time was observed for 9 hours after the intervention and assessed by Kaplan-Meier statistics. The overall survival in each group was compared using Fisher's exact test. Finally, we used a Cox proportional-hazards model to examine the effects of cytokine removal on survival time. MEASUREMENTS AND MAIN RESULTS: Baseline plasma cytokine concentrations and MAP were similar between hemoadsorption and sham-treated groups. However, the concentrations of tumor necrosis factor, interleukin (IL)-1beta, IL-6, and IL-10 were significantly lower after hemoadsorption compared to the sham group. Six hours after treatment ended, IL-6 and IL-10 concentrations were still lower in hemoadsorption group. MAP was significantly better in hemoadsorption compared to sham-treated animals (p < .05). Finally, mean survival time was significantly longer (720 vs. 381 min, p < .05, Mann-Whitney test), and overall survival was significantly better (11/17 vs. 2/16, p < .01) with hemoadsorption compared to sham. Combined reduction in both IL-6 and IL-10 was associated with a significantly decreased risk of death (hazard ratio, .11, p = .005). CONCLUSION: Hemoadsorption reduced circulating cytokines, improved MAP, and resulted in better short-term survival in CLP-induced septic rats.
OBJECTIVE: A broad-spectrum immune-regulating therapy could be beneficial in the treatment of sepsis. Our previous studies have shown that a hemoadsorption device (CytoSorb) removes both pro- and anti-inflammatory cytokines and improves survival in experimental endotoxemia. We sought to determine whether hemoadsorption can also be effective in the treatment of sepsis. DESIGN: Randomized controlled laboratory experiment. SETTING: University laboratory. INTERVENTIONS:Rats were subjected to cecal ligation and puncture (CLP) and 20 hrs later were randomized to receive either hemoadsorption or sham treatment using an arterial-venous circuit. Hemoadsorption was accomplished using a cartridge containing Cytosorb beads. Blood was drawn for cytokine measurements and mean arterial pressure (MAP) was continuously monitored. Cytokines were measured via multiplex bead immunoassays. Survival time was observed for 9 hours after the intervention and assessed by Kaplan-Meier statistics. The overall survival in each group was compared using Fisher's exact test. Finally, we used a Cox proportional-hazards model to examine the effects of cytokine removal on survival time. MEASUREMENTS AND MAIN RESULTS: Baseline plasma cytokine concentrations and MAP were similar between hemoadsorption and sham-treated groups. However, the concentrations of tumornecrosis factor, interleukin (IL)-1beta, IL-6, and IL-10 were significantly lower after hemoadsorption compared to the sham group. Six hours after treatment ended, IL-6 and IL-10 concentrations were still lower in hemoadsorption group. MAP was significantly better in hemoadsorption compared to sham-treated animals (p < .05). Finally, mean survival time was significantly longer (720 vs. 381 min, p < .05, Mann-Whitney test), and overall survival was significantly better (11/17 vs. 2/16, p < .01) with hemoadsorption compared to sham. Combined reduction in both IL-6 and IL-10 was associated with a significantly decreased risk of death (hazard ratio, .11, p = .005). CONCLUSION: Hemoadsorption reduced circulating cytokines, improved MAP, and resulted in better short-term survival in CLP-induced septic rats.
Authors: S Uchino; R Bellomo; D Goldsmith; P Davenport; L Cole; I Baldwin; S Panagiotopoulos; P Tipping Journal: Intensive Care Med Date: 2002-04-12 Impact factor: 17.440
Authors: John A Kellum; Lan Kong; Mitchell P Fink; Lisa A Weissfeld; Donald M Yealy; Michael R Pinsky; Jonathan Fine; Alexander Krichevsky; Russell L Delude; Derek C Angus Journal: Arch Intern Med Date: 2007 Aug 13-27
Authors: Jicheng Zhang; Zhiyong Peng; Donald Maberry; Jacob Volpe; Jeremy D Kimmel; William J Federspiel; John A Kellum Journal: Blood Purif Date: 2015-04-01 Impact factor: 2.614
Authors: Zhi-Yong Peng; Hong-Zhi Wang; Melinda J Carter; Morgan V Dileo; Jeffery V Bishop; Fei-Hu Zhou; Xiao-Yan Wen; Thomas Rimmelé; Kai Singbartl; William J Federspiel; Gilles Clermont; John A Kellum Journal: Kidney Int Date: 2011-09-14 Impact factor: 10.612
Authors: Joselito R Chavez; Romina A Danguilan; Melhatra I Arakama; Joann Kathleen Ginete Garcia; Rizza So; Eric Chua Journal: BMJ Case Rep Date: 2019-05-29
Authors: Zhi-Yong Peng; Jicheng Zhang; Thomas Rimmelé; Feihu Zhou; Anan Chuasuwan; A Murat Kaynar; John A Kellum Journal: J Surg Res Date: 2013-08-06 Impact factor: 2.192